Assessment of retroperitoneal lymph node status in locally advanced cervical cancer.

Abstract

BACKGROUND:

The assessment of retroperitoneal lymph node status in patients with locally advanced cervical cancer is still a problem. This study aimed to explore the choice of these assessment methods.

METHODS:

Laparoscopic retroperitoneal lymphadenectomy was performed in 96 patients with advanced cervical cancer. The positive rates of lymph node metastasis were analyzed. The values of computed tomography lymph node minimum axial diameter (MAD) and squamous cell carcinoma antigen (SCC-Ag), and their combination in predicting retroperitoneal lymph node metastasis were compared. High-risk factors for common iliac lymph node (CILN) and/or para-aortic lymph node (PALN) metastasis were analyzed.

RESULTS:

The lymph node metastasis rate was 62.50% and the CILN and/or PALN metastasis rate was 31.25%. Overall, 96 patients had 172 visible lymph nodes. The positive rate of lymph node metastasis was significantly higher in the MAD ≥1.0 cm group (83.33%) than in the 0.5 cm ≤ MAD < 1.0 cm group (26.82%). The critical values of MAD and SCC-Ag in determining lymph node metastasis were 1.0 cm and 5.2 ng/mL, respectively. The accuracy, specificity, and Youden index of MAD ≥1.0 cm combined with SCC-Ag ≥ 5.2 ng/mL for evaluating lymph node metastasis were 75.71%, 100%, and 0.59, respectively, and were significantly different from the values for the MAD ≥1.0 cm (72.09%, 80.56%, and 0.47, respectively) and SCC-Ag ≥ 5.2 ng/mL (71.43%, 68.97%, and 0.42, respectively) groups. Correlation analysis showed that non-squamous cell carcinoma, pelvic lymph node (PLN) MAD ≥1.0 cm plus number ≥ 2, and 1 PLN MAD ≥1.0 cm with CILN and/or PALN MAD 0.5-1.0 cm were risk factors for CILN and/or PALN metastasis.

CONCLUSION:

Patients with MAD ≥1.0 cm and SCC-Ag ≥ 5.2 ng/mL, as well as high risk factors for CILN and/or PALN metastasis, should undergo resection of enlarged lymph nodes below the common iliac gland and lymphadenectomy of CILN/PALN to reduce tumor burden and to clarify lymph node metastasis status for accurate guidance in follow-up treatment. Patients with MAD < 1.0 cm and SCC-Ag < 5.2 ng/mL may be treated with chemoradiotherapy directly based on imaging, given the low lymph node metastasis rate.

• Authors: Wei Li, Li Xiong, Qiaoling Zhu, Hong Lu, Meiling Zhong, Meirong Liang, Wei Jiang, Yanan Wang, Wei Cheng
• Journal: BMC cancer (BMC Cancer) Vol. 21 Issue 1 Pg. 484 (May 01 2021) ISSN: 1471-2407 [Electronic] England
• PMID: 33933005 (Publication Type: Journal Article)

Chemical References

• Antigens, Neoplasm
• Serpins
• squamous cell carcinoma-related antigen

Topics

• Adult
• Aged
• Antigens, Neoplasm (blood)
• Area Under Curve
• Carcinoma (blood, diagnostic imaging, pathology, therapy)
• Carcinoma, Squamous Cell (blood, diagnostic imaging, pathology, therapy)
• Female
• Humans
• Laparoscopy
• Lymph Node Excision (methods)
• Lymph Nodes (diagnostic imaging, immunology, pathology)
• Lymphatic Metastasis (pathology)
• Middle Aged
• Radiotherapy, Intensity-Modulated
• Retroperitoneal Space
• Risk Factors
• Sensitivity and Specificity
• Serpins (blood)
• Tomography, Spiral Computed
• Uterine Cervical Neoplasms (blood, diagnostic imaging, pathology, therapy)
• Young Adult